A potent and selective indole N-type calcium channel (Cav2.2) blocker for the treatment of pain
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (2) , 869-873
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Recent Updates of N-Type Calcium Channel Blockers with Therapeutic Potential for Neuropathic Pain and StrokeCurrent Topics in Medicinal Chemistry, 2009
- Voltage-gated calcium channels and painPain, 2006
- Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic painExpert Review of Neurotherapeutics, 2006
- A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic PainJournal of Pain and Symptom Management, 2006
- Targeting N-type and T-type calcium channels for the treatment of painDrug Discovery Today, 2006
- Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic PainCurrent Medicinal Chemistry, 2004
- Voltage-Gated Calcium Channels as Targets for the Treatment of Chronic PainCurrent Drug Targets-CNS & Neurological Disorders, 2004
- Localization of N-type Ca 2+ channels in the rat spinal cord following chronic constrictive nerve injuryExperimental Brain Research, 2002
- Localization of Ca2+Channel Subtypes on Rat Spinal Motor Neurons, Interneurons, and Nerve TerminalsJournal of Neuroscience, 1998
- Three types of neuronal calcium channel with different calcium agonist sensitivityNature, 1985